-
Danish Pharmacovigilance Update, 26 September 2013
| 21 November 2013 |
In this issue of Danish Pharmacovigilance Update: Filgrastim (Neupogen) and pegfilgrastim (Neulasta) are associated with risk of capillary leak syndrome.
You must accept marketing cookies to share the page by mail
Update consentIn this issue of Danish Pharmacovigilance Update: Filgrastim (Neupogen) and pegfilgrastim (Neulasta) are associated with risk of capillary leak syndrome.